187 related articles for article (PubMed ID: 35891648)
1. Identification and validation of immune related core transcription factors
Zhang M; Zhang Y; Jiao X; Lai L; Qian Y; Sun B; Yang W
PeerJ; 2022; 10():e13735. PubMed ID: 35891648
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
3. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.
Jiang H; Hu Y; Zhang Z; Chen X; Gao J
Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333
[TBL] [Abstract][Full Text] [Related]
4. Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis.
He Y; Li J; Qu Y; Sun L; Zhao X; Wu H; Zhang G
J Immunol Res; 2023; 2023():2975581. PubMed ID: 36660246
[TBL] [Abstract][Full Text] [Related]
5. Identification of m6A-associated autophagy genes in non-alcoholic fatty liver.
Huang Z; Luo L; Wu Z; Xiao Z; Wen Z
PeerJ; 2024; 12():e17011. PubMed ID: 38436022
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease.
Zhang H; Axinbai M; Zhao Y; Wei J; Qu T; Kong J; He Y; Zhang L
Eur J Med Res; 2023 Dec; 28(1):605. PubMed ID: 38115130
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
[TBL] [Abstract][Full Text] [Related]
8. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.
Chu Y; Yu F; Wu Y; Yang J; Shi J; Ye T; Han D; Wang X
BMC Med Genomics; 2022 Jul; 15(1):150. PubMed ID: 35790963
[TBL] [Abstract][Full Text] [Related]
9. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease.
Zhang J; Wang L; Jiang M
Medicine (Baltimore); 2024 Feb; 103(8):e37185. PubMed ID: 38394483
[TBL] [Abstract][Full Text] [Related]
11. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
12. Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis.
Huang R; Wang S; Zhu R; Xian S; Huang Z; Cheng L; Zhang J
Front Cell Dev Biol; 2021; 9():728242. PubMed ID: 34708039
[No Abstract] [Full Text] [Related]
13. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach.
Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY
Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262
[TBL] [Abstract][Full Text] [Related]
14. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
Wang J; Liu H; Xie G; Cai W; Xu J
Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
[TBL] [Abstract][Full Text] [Related]
16. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
Dong Q; Han Z; Tian L
Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
[TBL] [Abstract][Full Text] [Related]
17. Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD).
Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
Eur J Med Res; 2022 Nov; 27(1):251. PubMed ID: 36380355
[TBL] [Abstract][Full Text] [Related]
18. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis.
Qi S; Wang C; Li C; Wang P; Liu M
Medicine (Baltimore); 2017 Aug; 96(32):e7743. PubMed ID: 28796060
[TBL] [Abstract][Full Text] [Related]
19. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Huang S; Sun C; Hou Y; Tang Y; Zhu Z; Zhang Z; Zhang Y; Wang L; Zhao Q; Chen MG; Guo Z; Wang D; Ju W; Zhou Q; Wu L; He X
Sci Rep; 2018 May; 8(1):7630. PubMed ID: 29769552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
